Trial test of sorafenib alone or in combination with chemotherapy for treating refractory and relapsed acute myeloid leukemia with FLT3 mutation

Authors
Category Primary study
JournalBlood
Year 2014
This article has no abstract
Epistemonikos ID: dc6cf8c4bf9a4d490c5de2070e82aedf0ebe61c0
First added on: Feb 06, 2025